SCHEMBL30658292

SCHEMBL30658292

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)Cc1ccccc1)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)C)[C@@H](C)O

nearest known ligand 0.82

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.71
▸ NPY2R P49146 9/20 0.65
▸ NPY4R P50391 8/20 0.65
▸ NPY5R Q15761 8/20 0.65
▸ NPY1R P25929 7/20 0.65
▸ TFPI P10646 3/20 0.63
▸ GLP1R P43220 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30578734 0.96 CALCR (0.73) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30578729 0.94 CALCR (0.73) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30578733 0.94 CALCR (0.73) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29523674 0.94 CALCR (0.70) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30658322 0.93 NPY2R (0.68) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30578732 0.93 NPY2R (0.74) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30433571 0.92 NPY2R (0.69) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30658358 0.91 CALCR (0.77) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30843963 0.91 CALCR (0.71) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29530680 0.91 CALCR (0.67) CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753627-B2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2023-09-12 — — US disclosed
Send feedback